Literature DB >> 27256749

Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction.

John R Kapoor1, Roger Kapoor2, Christine Ju3, Paul A Heidenreich4, Zubin J Eapen3, Adrian F Hernandez3, Javed Butler5, Clyde W Yancy6, Gregg C Fonarow7.   

Abstract

OBJECTIVES: This study assessed the comparative frequency of precipitating clinical factors leading to hospitalization among heart failure (HF) patients with reduced, borderline, and preserved ejection fraction (EF)
BACKGROUND: There are few data assessing the comparative frequency of clinical factors leading to HF among hospitalized among patients with reduced, borderline, and preserved EF.
METHODS: We analyzed the factors potentially contributing to HF hospitalization among 99,825 HF admissions from 305 hospitals in the Get With The Guidelines-HF (GWTG-HF) database between January 2005 and September 2013 and assessed their association with length of stay and in-hospital mortality.
RESULTS: Mean patient age was 72.6 ± 14.2 years, 49% were female, and mean EF was 39.3 ± 17.2%. Common factors included pneumonia/respiratory process (28.2%), arrhythmia (21.7%), medication noncompliance (15.8%), worsening renal failure (14.7%), and uncontrolled hypertension (14.5%). In patients with borderline EF (EF 40% to 49%), pneumonia was associated with longer hospital stay, whereas dietary and medication noncompliance were associated with reduced length of stay. In patients with preserved EF (EF ≥50% or qualitative assessment of normal or mild dysfunction), pneumonia, weight gain, and worsening renal function were independently associated with longer lengths of stay. Worsening renal function and pneumonia were independently associated with higher in-hospital mortality in all HF groups, and acute pulmonary edema was associated with higher mortality in reduced EF. Dietary noncompliance (14.7%) was associated with reduced mortality for all groups but reached statistical significance in the subgroups of reduced (odds ratio [OR]: 0.65; 95% confidence interval [CI]: 0.46 to 0.91) and preserved systolic function (OR: 0.52; 95% CI: 0.33 to 0.83). Patients presenting with ischemia had a higher mortality rate (OR: 1.31; 95% CI: 1.02 to 1.69; and 1.72; 95% CI: 1.27 to 2.33, respectively, in the 2 groups).
CONCLUSIONS: Potential precipitating factors among patients hospitalized with HF vary by EF group and are independently associated with clinical outcomes.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure; outcomes; precipitating factors

Mesh:

Year:  2016        PMID: 27256749     DOI: 10.1016/j.jchf.2016.02.017

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  60 in total

1.  Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.

Authors:  Xiaojing Chen; Gianluigi Savarese; Ulf Dahlström; Lars H Lund; Michael Fu
Journal:  Clin Res Cardiol       Date:  2019-04-12       Impact factor: 5.460

2.  Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation.

Authors:  Hua He; XiaoDong Li; BingBing Ke; Zhuo Chen; FuSheng Han; YuJie Zeng
Journal:  J Interv Card Electrophysiol       Date:  2019-02-09       Impact factor: 1.900

3.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

4.  Transesophageal Echocardiography, Acute Kidney Injury, and Length of Hospitalization Among Adults Undergoing Coronary Artery Bypass Graft Surgery.

Authors:  Emily J MacKay; Rachel M Werner; Peter W Groeneveld; Nimesh D Desai; Peter P Reese; Jacob T Gutsche; John G Augoustides; Mark D Neuman
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-08-28       Impact factor: 2.628

5.  Effects of glycemic control on in-hospital mortality among acute heart failure patients with reduced, mid-range, and preserved ejection fraction.

Authors:  Kenichi Matsushita; Kazumasa Harada; Tetsuro Miyazaki; Takamichi Miyamoto; Kiyoshi Iida; Shuzou Tanimoto; Mayuko Yagawa; Makoto Takei; Yuji Nagatomo; Toru Hosoda; Hideaki Yoshino; Takeshi Yamamoto; Ken Nagao; Morimasa Takayama
Journal:  Heart Vessels       Date:  2018-03-14       Impact factor: 2.037

6.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

7.  Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.

Authors:  Elke Platz; Pardeep S Jhund; Brian L Claggett; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Salim Yusuf; Scott D Solomon; John J McMurray
Journal:  Eur J Heart Fail       Date:  2017-09-04       Impact factor: 15.534

8.  Predictors and outcomes of heart failure with mid-range ejection fraction.

Authors:  Vijeta Bhambhani; Jorge R Kizer; Joao A C Lima; Pim van der Harst; Hossein Bahrami; Matthew Nayor; Christopher R de Filippi; Danielle Enserro; Michael J Blaha; Mary Cushman; Thomas J Wang; Ron T Gansevoort; Caroline S Fox; Hanna K Gaggin; Willem J Kop; Kiang Liu; Ramachandran S Vasan; Bruce M Psaty; Douglas S Lee; Frank P Brouwers; Hans L Hillege; Traci M Bartz; Emelia J Benjamin; Cheeling Chan; Matthew Allison; Julius M Gardin; James L Januzzi; Daniel Levy; David M Herrington; Wiek H van Gilst; Alain G Bertoni; Martin G Larson; Rudolf A de Boer; John S Gottdiener; Sanjiv J Shah; Jennifer E Ho
Journal:  Eur J Heart Fail       Date:  2017-12-11       Impact factor: 15.534

Review 9.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

Review 10.  Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies.

Authors:  Peter Unkovic; Anupam Basuray
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.